Interleukin-18 Promoter Gene Polymorphisms are not Associated with Myocardial Infarction in Type 2 Diabetes in Slovenia

Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999; 340(2): 115-126.10.1056/NEJM1999011434002079887164Search in Google Scholar

Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998; 41(10): 1241-1248.10.1007/s0012500510589794114Search in Google Scholar

Libby P. Inflammation in atherosclerosis. Nature. 2002; 420(6917):868-874.10.1038/nature0132312490960Search in Google Scholar

Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med. 2000; 342(14): 1040-1042.10.1056/NEJM20000406342140810749967Search in Google Scholar

Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med. 2002; 195(2): 245-257.10.1084/jem.20011022219360711805151Search in Google Scholar

Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001; 104(104): 1598-1603.10.1161/hc3901.09672111581135Search in Google Scholar

Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-γ. Circ Res. 2002; 90(2): e34-e38.10.1161/hh0202.10529211834721Search in Google Scholar

Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res. 2001; 89(7): e41-e45.10.1161/hh1901.09873511577031Search in Google Scholar

Mallat Z, Henry P, Fressonnet R, Alouani S, Scoazec A, Beaufils P, Chvatchko Y, Tedgui A. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart. 2002; 88(5): 467-469.10.1136/heart.88.5.467176743112381634Search in Google Scholar

Esposito K, Nappo F, Giugliano D, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D. Cyokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care. 2003; 26(5): 1647.10.2337/diacare.26.5.164712716849Search in Google Scholar

Aso Y, Okumura KI, Takebayashi K, Wakabayashi S, Inukai T. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intima-media wall thickness in patients with type 2 diabetes. Diabetes Care. 2003; 26(9): 2622-2627.10.2337/diacare.26.9.2622Search in Google Scholar

Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002; 106:(16): 2067-2072.10.1161/01.CIR.0000034509.14906.AESearch in Google Scholar

Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001; 112(1-2): 146-152.10.1016/S0165-5728(00)00407-0Search in Google Scholar

Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, Barbaux S, Schnabel R, Bickel C, Espinola-Klein C, Poirier O, Perret C, Munzel T, Rupprecht HJ, Lackner K, Cambien F, Blankenberg S, for the AtheroGene Investigators. Genetic analysis of the interleukin-18 aystem highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation. 2005; 112(5): 643-650.10.1161/CIRCULATIONAHA.104.519702Search in Google Scholar

Hernesniemi JA, Karhunen PJ, Rontu R, Ilveskoski E, Kajander O, Goebeler S, Viiri LE, Pessi T, Hurme M, Lehtimäki T. Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: The Helsinki Sudden Death Study. Atherosclerosis. 2008; 196(2): 643-649.10.1016/j.atherosclerosis.2007.07.018Search in Google Scholar

Liu W, Tang Q, Jiang H, Ding X, Liu Y, Zhu R, Tang Y, Li B, Wei M. Promoter polymorphism of inerleukin-18 in angiographically proven coronary artery disease. Angiology. 2009; 60(2): 180-185.10.1177/0003319708319939Search in Google Scholar

Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M, Puchalski Z, Kinalska I. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes. 2002; 51(11): 3347-3349.10.2337/diabetes.51.11.3347Search in Google Scholar

Bossu P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, Trequattrini A, Macciardi F, Spoletini I, Di Iulio F, Caltagirone C, Spalletta G. Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78(8): 807-811.10.1136/jnnp.2006.103242Search in Google Scholar

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26(Suppl 1): S5-S20.10.2337/diacare.26.2007.S5Search in Google Scholar

Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36(3): 959-969.10.1016/S0735-1097(00)00804-4Search in Google Scholar

Szeszko JS, Howson JM, Cooper JD, Walker NM, Twells RC, Stevens HE, Nutland SL, Todd JA. Analysis of polymorphisms of the interleukin-18 gene in type 1 diabetes and Hardy-Weinberg equilibrium testing. Diabetes. 2006; 55(2): 559-562.10.2337/diabetes.55.02.06.db05-082616443795Search in Google Scholar

Ford E. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999; 22(12): 1971-1977.Search in Google Scholar

Schulze M, Rifai N, Rimm E, Stampfer M, Li T, Hu F. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care. 2004; 27(4): 889-894.10.2337/diacare.27.4.88915047644Search in Google Scholar

Soinio M, Marniemi J, Laakso M, Lehto S, Rönnemaa T. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care. 2006; 29(2): 329-333.10.2337/diacare.29.02.06.dc05-170016443882Search in Google Scholar

Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care. 2005; 28(12): 2890-2895.10.2337/diacare.28.12.289016306550Search in Google Scholar

Troseid M, Seljeflot I, Hjerkinn EM, Arnesen H. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care. 2009; 32(3): 486-492.10.2337/dc08-1710264603419092166Search in Google Scholar

Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes. 2005; 54(10): 2932-2938.10.2337/diabetes.54.10.293216186395Search in Google Scholar

Tenger C, Sundborger A, Jawien J, Zhou X. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells. Arterioscler Thromb Vasc Biol. 2005; 25(4): 791-796.10.1161/01.ATV.0000153516.02782.6515604417Search in Google Scholar

Rosso R, Roth A, Herz I, Miller H, Keren G, George J. Serum levels of interleukin-18 in patients with stable and unstable angina pectoris. Int J Cardiol. 2005; 98(1): 45-48.10.1016/j.ijcard.2003.08.02015676165Search in Google Scholar

Hulthe J, McPheat W, Samnegard A, Tornvall P, Hamsten A, Eriksson P. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis. 2006; 188(2): 450-454.10.1016/j.atherosclerosis.2005.11.01316405895Search in Google Scholar

Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht Interleukin 18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002; HJ. 106(1): 24-30.10.1161/01.CIR.0000020546.30940.9212093765Search in Google Scholar

Blankenberg S, Luc G, Ducimetière P, Arveiler D, Ferrières J, Amouyel P, Evans A, Cambien F, Tiret L, on behalf of the PRIME Study Group. Interleukin-18 and the risk of coronary heart disease in European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2003; 108(20): 2453-2459.10.1161/01.CIR.0000099509.76044.A214581397Search in Google Scholar

Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, Ogata A, Shima Y, Fujimoto M, Yamadori T, Hagiwara K, Ohgawara T, Kuwabara Y, Kawase I, Tanaka T. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun. 2006; 342(4): 1413-1416.10.1016/j.bbrc.2006.02.09616516851Search in Google Scholar

Hernesniemi JA, Karhunen PJ, Oksala N, Kähönen M, Levula M, Rontu R, Ilveskoski E, Kajander O, Goebeler S, Viiri LE, Hurme M, Lehtimäki T. Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study. Eur Heart J. 2009; 30(23): 2939-2946.10.1093/eurheartj/ehp31619687159Search in Google Scholar

Kathiresan S, Newton-Cheh C, Gerszten RE. On the interpretation of genetic association studies. Eur Heart J. 2004; 25(16): 1378-1381.10.1016/j.ehj.2004.06.03515321696Search in Google Scholar